Early intravenous beta-blockade before primary percutaneous coronary intervention gives major benefits, apparently without side effects

Journal of the American College of Cardiology

Volumn 64, Issue 17, 2014, Pages 1864-

  Opie, Lionel H ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; METOPROLOL; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;

ACUTE HEART INFARCTION; AWARENESS; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; CLINICAL TRIAL (TOPIC); DRUG PREFERENCE; EARLY INTERVENTION; HEART BLOCK; HEART VENTRICLE FIBRILLATION; HUMAN; HYPOTENSION; LETTER; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; RISK BENEFIT ANALYSIS; RISK REDUCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TIME TO TREATMENT; MYOCARDIAL INFARCTION;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; EARLY MEDICAL INTERVENTION; HUMANS; METOPROLOL; MYOCARDIAL INFARCTION;

EID: 84908181238     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.07.976     Document Type: Letter

References (3)

1. G. Pizarro, L. Fernández-Friera, and V. Fuster Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction) J Am Coll Cardiol 63 2014 2356 2362
2. Z.M. Chen, H.C. Pan, and Y.P. Chen Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. COMMIT (Clopidogrel and Metoprolol in Myocardial Infarction Trial) Collaborative Group Lancet 366 2005 1622 1632
3. S. Yusuf Early intravenous beta blockade in acute myocardial infarction Postgrad Med Spec No 1988 90 95